2022
DOI: 10.3390/molecules27238529
|View full text |Cite
|
Sign up to set email alerts
|

PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[18F]fluoro-6-deoxy-D-fructose

Abstract: Fluorine-18 labeled 6-fluoro-6-deoxy-D-fructose (6-[18F]FDF) targets the fructose-preferred facilitative hexose transporter GLUT5, which is expressed predominantly in brain microglia and activated in response to inflammatory stimuli. We hypothesize that 6-[18F]FDF will specifically image microglia following neuroinflammatory insult. 6-[18F]FDF and, for comparison, [18F]FDG were evaluated in unilateral intra-striatal lipopolysaccharide (LPS)-injected male and female rats (50 µg/animal) by longitudinal dynamic P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 69 publications
0
4
0
Order By: Relevance
“…Preclinical PET imaging studies were approved by the Animal Care Committee at CAMH (Animal Use Protocol #838). Six adult Sprague-Dawley rats were scanned for 120 min on either a Mediso nanoScan PET/MR 3 T or PET/CT scanner (Budapest, Hungary), and the images were analyzed using VivoQuant® software (version 4.1, Invicro LLC, Needham, MA, USA), as described previously [20]. Five rats (3 M/2F, 528 ± 46 g ) were used for the baseline [ 18 F]SynVesT-1 scans (injected dose: 13.3 ± 3.2 MBq ; molar activity: 157 ± 64 GBq / μ mol ; mass injected: 0.22 ± 0.08 nmol / kg ), with two of the male rats also scanned after injection of the blocking drug levetiracetam (cat#L1784, LKT Laboratories Inc, St Paul, MN, USA) at 30 mg/kg (i.v., 15 min before the tracer; injected dose: 10.2 ± 0.1 MBq ; molar activity: 78 ± 15 GBq/ μ mol; injected mass: 0.24 ± 0.04 nmol/kg).…”
Section: Methodsmentioning
confidence: 99%
“…Preclinical PET imaging studies were approved by the Animal Care Committee at CAMH (Animal Use Protocol #838). Six adult Sprague-Dawley rats were scanned for 120 min on either a Mediso nanoScan PET/MR 3 T or PET/CT scanner (Budapest, Hungary), and the images were analyzed using VivoQuant® software (version 4.1, Invicro LLC, Needham, MA, USA), as described previously [20]. Five rats (3 M/2F, 528 ± 46 g ) were used for the baseline [ 18 F]SynVesT-1 scans (injected dose: 13.3 ± 3.2 MBq ; molar activity: 157 ± 64 GBq / μ mol ; mass injected: 0.22 ± 0.08 nmol / kg ), with two of the male rats also scanned after injection of the blocking drug levetiracetam (cat#L1784, LKT Laboratories Inc, St Paul, MN, USA) at 30 mg/kg (i.v., 15 min before the tracer; injected dose: 10.2 ± 0.1 MBq ; molar activity: 78 ± 15 GBq/ μ mol; injected mass: 0.24 ± 0.04 nmol/kg).…”
Section: Methodsmentioning
confidence: 99%
“…Within this class of receptors, synthetic antibodies have recently been linked to PET-radioligands targeting the TrkB receptor, activated by brain derived neurotrophic factor (BDNF), which have passed the preclinical and clinical assessments. [103][104][105] While this research still is in the experimental phase, the recent development of TrkB agonistic antibodies and BDNFtargeted gene therapies 106,107 could prove useful as an alternative line of therapy to amyloid modifying treatments, and changes in TrkB alterations as measured by PET/MRI during targeted therapy could potentially qualify as an imaging endpoint in clinical trials in AD. In Canada, TrkB PET using the novel tracer [ 18 F]-TRACK is currently available or in use for clinical trials at the Universities of Alberta and Montréal.…”
Section: Alpha-synuclein Pet Imagingmentioning
confidence: 99%
“…To address the issues related to imaging of neuroinflammation, Vasdev et al synthesized 6-fluoro-6deoxy-D-fructose (6-[ 18 F]FDF), and in vitro studies suggested that it can be an early biomarker for neuroinflammations. 58 Readers can refer to the cited review for recent advances in 18 F-fluoroglycosylation reactions and their preclinical applications. 59 Understanding structure-function relationships between various carbohydrates and biological systems is essential in comprehending how cells function and communicate.…”
Section: Rsc Medicinal Chemistry Reviewmentioning
confidence: 99%